8-K Announcements
6May 27, 2025·SEC
May 12, 2025·SEC
May 1, 2025·SEC
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant strengths identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) stock price & volume — 10-year historical chart
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) EPS & revenue vs analyst estimates — last 3 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2023Latest | Sep 30, 2023 | $0.04 | $22M |
| Q2 2023 | Mar 31, 2023 | $0.11 | $19M |
| Q4 2022 | Dec 31, 2022 | $0.25 | $10M |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) competitors in Reinsurers and hybrid reinsurance groups — business model, growth, and fundamentals comparison
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.05B | 2.14B | 2.16B | 576.13M | 184.12M | 98.72M | 58.13M | 89.23M | 56.44M | 41.58M |
| Revenue Growth % | -20.26% | 4.24% | 1.22% | -73.39% | -68.04% | -46.38% | -41.11% | 53.5% | -36.75% | -57.85% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Medical Cost Ratio % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Gross Profit | 2.05B▲ 0% | 2.14B▲ 4.2% | 2.16B▲ 1.2% | 576.13M▼ 73.4% | 184.12M▼ 68.0% | 98.72M▼ 46.4% | 58.13M▼ 41.1% | 89.23M▲ 53.5% | 56.44M▼ 36.8% | 41.58M▲ 0% |
| Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -20.26% | 4.24% | 1.22% | -73.39% | -68.04% | -46.38% | -41.11% | 53.5% | -36.75% | - |
| Operating Expenses | 1.94B | 2.27B | 2.6B | 667.09M | 39.12M | 36.02M | 30.95M | 30.8M | 35.35M | 23.5M |
| OpEx / Revenue % | 94.64% | 106% | 119.89% | 115.79% | 21.25% | 36.49% | 53.24% | 34.51% | 62.63% | 56.52% |
| Depreciation & Amortization | 20.3M | 5.45M | 4.9M | 5.91M | 6.24M | 3.45M | 49.32M | 2.75M | 0 | -843K |
| Combined Ratio % | 94.64% | 106% | 119.89% | 115.79% | 21.25% | 36.49% | 53.24% | 34.51% | 62.63% | 56.52% |
| Operating Income | 96.58M▲ 0% | -113.42M▼ 217.4% | -429.49M▼ 278.7% | -93.67M▲ 78.2% | 145M▲ 254.8% | 62.7M▼ 56.8% | 27.18M▼ 56.6% | 58.44M▲ 115.0% | 21.09M▼ 63.9% | 3.52M▲ 0% |
| Operating Margin % | 4.71% | -5.3% | -19.84% | -16.26% | 78.75% | 63.51% | 46.76% | 65.49% | 37.37% | 8.47% |
| Operating Income Growth % | -34.58% | -217.43% | -278.69% | 78.19% | 254.8% | -56.76% | -56.64% | 114.96% | -63.91% | - |
| EBITDA | 116.88M | -107.97M | -424.59M | -87.76M | 151.25M | 66.15M | 76.5M | 61.18M | 21.09M | -4.41M |
| EBITDA Margin % | 5.7% | -5.05% | -19.61% | -15.23% | 82.15% | 67.01% | 131.6% | 68.56% | 37.37% | -10.62% |
| Interest Expense | 0 | 0 | 0 | 0 | 19.32M | 0 | 0 | 0 | 19.27M | 19.27M |
| Non-Operating Income | -2B | -2.09B | -2.11B | -528.92M | -145M | -62.7M | -27.18M | -58.44M | 201.74M | 212.35M |
| Pretax Income | 79.47M▲ 0% | -154.41M▼ 294.3% | -449.85M▼ 191.3% | -110.27M▲ 75.5% | 41.66M▲ 137.8% | 26.66M▼ 36.0% | -60.6M▼ 327.3% | -38.37M▲ 36.7% | -199.91M▼ 421.0% | -210.02M▲ 0% |
| Pretax Margin % | 3.87% | -7.22% | -20.78% | -19.14% | 22.63% | 27.01% | -104.24% | -43% | -354.23% | -505.08% |
| Income Tax | 413K | -6.76M | 441K | -911K | -104K | 15K | -557K | 196K | 1.05M | 1.06M |
| Effective Tax Rate % | 0.52% | 4.38% | -0.1% | 0.83% | -0.25% | 0.06% | 0.92% | -0.51% | -0.53% | -0.5% |
| Net Income | 46.14M▲ 0% | -176.98M▼ 483.6% | -476.16M▼ 169.1% | -109.36M▲ 77.0% | 41.76M▲ 138.2% | 26.64M▼ 36.2% | -60.04M▼ 325.3% | -38.57M▲ 35.8% | -200.97M▼ 421.1% | -211.06M▲ 0% |
| Net Margin % | 2.25% | -8.27% | -22% | -18.98% | 22.68% | 26.99% | -103.28% | -43.22% | -356.1% | -507.58% |
| Net Income Growth % | -53.9% | -483.58% | -169.05% | 77.03% | 138.19% | -36.2% | -325.34% | 35.76% | -421.06% | -718.08% |
| EPS (Diluted) | 0.59▲ 0% | -2.07▼ 450.8% | -5.73▼ 176.8% | -1.32▲ 77.0% | 0.93▲ 170.5% | 1.35▲ 45.2% | 0.63▼ 53.3% | -0.38▼ 160.3% | -2.01▼ 428.9% | -2.13▲ 0% |
| EPS Growth % | -49.57% | -450.85% | -176.81% | 76.96% | 170.45% | 45.16% | -53.33% | -160.32% | -428.95% | 57.72% |
| EPS (Basic) | 0.58 | -2.07 | -5.74 | -1.32 | 0.93 | 1.35 | 0.63 | -0.38 | -2.01 | - |
| Diluted Shares Outstanding | 78.69M | 85.68M | 83.05M | 83.06M | 84.33M | 86.07M | 87.11M | 101.38M | 99.9M | 99.12M |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 6.25B | 6.64B | 5.29B | 3.57B | 2.95B | 2.32B | 1.85B | 1.52B | 1.32B | 1.23B |
| Asset Growth % | 10.81% | 6.27% | -20.42% | -32.52% | -17.37% | -21.23% | -20.48% | -17.76% | -13.36% | 95.97% |
| Total Investment Assets | 74.28M | 112.13M | 156.49M | 197.66M | 106.9M | 291.21M | 229.3M | 263.74M | 0 | 0 |
| Long-Term Investments | 13.06M | 6.6M | 23.72M | 31.75M | 106.9M | 225.47M | 228.91M | 263.74M | 0 | 0 |
| Short-Term Investments | 61.22M | 105.53M | 132.78M | 165.91M | 0 | 65.74M | 386K | 0 | 0 | 0 |
| Total Current Assets | 757.37M | 356.2M | 558.9M | 1.61B | 1.5B | 1.36B | 1.06B | 35.41M | 55.54M | 65.98M |
| Cash & Equivalents | 149.53M | 149.38M | 330.99M | 107.28M | 74.04M | 66.09M | 46.62M | 35.41M | 34.73M | 44.27M |
| Receivables | 0 | 345.04M | 0 | 696.62M | 660.58M | 655.92M | 452.12M | 0 | 20.81M | 67.21M |
| Other Current Assets | 757.37M | 0 | 558.9M | 1.61B | 1.5B | 1.36B | 1.06B | 0 | 0 | 0 |
| Goodwill & Intangibles | 502.32M | 380.2M | 388.44M | 77.36M | 51.9M | 36.7M | 24.98M | 17.57M | 8.1M | 37.29M |
| Goodwill | 57.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 445.13M | 380.2M | 388.44M | 77.36M | 51.9M | 36.7M | 24.98M | 17.57M | 8.1M | 5.52M |
| PP&E (Net) | 0 | 0 | 0 | 2.34M | 1.64M | 473K | 300K | 228K | 0 | 1.34M |
| Other Assets | 4.98B | 5.9B | 4.32B | 1.41B | 1.32B | 1.25B | 478.08M | 171.86M | 1.25B | 1.23B |
| Total Liabilities | 4.89B | 5.41B | 4.73B | 3.06B | 2.42B | 1.94B | 1.56B | 1.27B | 1.27B | 1.2B |
| Total Debt | 351.41M | 254.48M | 254.69M | 254.91M | 255.13M | 255.35M | 255.87M | 254.6M | 254.76M | 254.8M |
| Net Debt | 201.87M | 105.11M | -76.3M | 147.63M | 119.3M | 189.26M | 209.25M | 219.19M | -34.73M | 210.53M |
| Long-Term Debt | 351.41M | 254.48M | 254.69M | 254.91M | 255.13M | 255.35M | 255.57M | 254.6M | 254.76M | 254.8M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201K | 0 | 0 |
| Total Current Liabilities | 3.06B | 2.48B | 3.12B | 30.1M | 51.36M | 1.53B | 1.24B | 24.03M | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 47.71M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -167.74M | -90.07M | -66.18M | 0 | 0 | 1.49B | 1.15B | -201K | 0 | -45.95M |
| Deferred Taxes | 0 | 0 | 0 | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 |
| Other Liabilities | 4.54B | 5.16B | 4.48B | 0 | 53M | 44.54M | 1.31B | 991.14M | 1.02B | 942.21M |
| Total Equity | 1.36B▲ 0% | 1.23B▼ 9.4% | 554.92M▼ 55.0% | 507.72M▼ 8.5% | 527.82M▲ 4.0% | 384.26M▼ 27.2% | 284.58M▼ 25.9% | 249.16M▼ 12.4% | 45.19M▼ 81.9% | 37.57M▲ 0% |
| Equity Growth % | 0.89% | -9.44% | -54.98% | -8.51% | 3.96% | -27.2% | -25.94% | -12.45% | -81.86% | -199.31% |
| Shareholders Equity | 1.36B | 1.23B | 554.27M | 507.72M | 527.82M | 384.26M | 284.58M | 249.16M | 45.19M | 37.57M |
| Minority Interest | 355K | 452K | 641K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 285.66M | 35.47M | -563.89M | -695.79M | -615.84M | -498.3M | -442.86M | -486.94M | -687.91M | -696.56M |
| Common Stock | 873K | 877K | 879K | 882K | 898K | 923K | 1.49M | 1.5M | 1.5M | 1.51M |
| Accumulated OCI | 15M | 13.35M | -65.62M | 17.84M | 23.86M | -12.21M | -41.23M | -31.47M | -32.73M | -31.93M |
| Return on Equity (ROE) | 3.4% | -13.65% | -53.28% | -20.58% | 8.07% | 5.84% | -17.95% | -14.45% | -136.55% | -561.72% |
| Return on Assets (ROA) | 0.78% | -2.74% | -7.98% | -2.47% | 1.28% | 1.01% | -2.88% | -2.29% | -14.18% | -17.1% |
| Equity / Assets | 21.77% | 18.55% | 10.49% | 14.23% | 17.9% | 16.54% | 15.41% | 16.4% | 3.43% | 3.04% |
| Debt / Equity | 0.26x | 0.21x | 0.46x | 0.50x | 0.48x | 0.66x | 0.90x | 1.02x | 5.64x | 5.64x |
| Book Value per Share | 17.30 | 14.39 | 6.68 | 6.11 | 6.26 | 4.46 | 3.27 | 2.46 | 0.45 | 0.38 |
| Tangible BV per Share | 10.91 | 9.95 | 2.00 | 5.18 | 5.64 | 4.04 | 2.98 | 2.28 | 0.37 | 0.32 |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 470.13M | 458.57M | 182.29M | -1.14B | -541.77M | -394.43M | -195.93M | -59.78M | -67.45M | -67.45M |
| Operating CF Growth % | -25.88% | -2.46% | -60.25% | -726.81% | 52.58% | 27.2% | 50.33% | 69.49% | -12.83% | -1184.19% |
| Operating CF / Revenue % | 22.91% | 21.44% | 8.42% | -198.32% | -294.25% | -399.54% | -337.04% | -66.99% | -119.51% | -162.21% |
| Net Income | 48.97M | -147.82M | -450.53M | -109.36M | 41.76M | 25.62M | -60.35M | -38.57M | -200.97M | -211.06M |
| Depreciation & Amortization | 20.3M | 5.45M | 4.9M | 5.91M | 6.24M | 3.45M | -2.85M | 2.75M | 0 | 843K |
| Stock-Based Compensation | 3.41M | 2.94M | 1.28M | 1.91M | 2.44M | 4.77M | 2.74M | 1.73M | -5.26M | -11.69M |
| Deferred Taxes | 0 | 0 | 0 | -13.73M | -14.93M | -11.68M | 112K | -7.21M | 0 | 0 |
| Other Non-Cash Items | 21.39M | 50.7M | -85.1M | -19.08M | -81.43M | -55.7M | -33.03M | -30.06M | -30.99M | 187.67M |
| Working Capital Changes | 420.08M | 561.14M | 722.82M | -1.01B | -495.87M | -360.9M | -102.55M | 11.6M | 169.77M | -30.94M |
| Cash from Investing | -439.2M | -359.86M | 32.9M | 913.18M | 596.04M | 464.06M | 188.79M | 58.51M | 77.74M | 74.83M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -421K | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 255.92M | 0 | 0 | 421K | 2.73M | 0 | 0 | 0 |
| Purchase of Investments | -1.37B | -838.89M | -1.02B | -2.02B | -532.07M | -367.29M | -191.87M | -247.84M | -37.77M | -42.35M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 0 |
| Other Investing | 138.24M | -51.82M | 102.79M | -2.87M | -608K | 396K | -88K | 306.35M | 14.57M | 13.94M |
| Cash from Financing | -76.78M | -60.42M | -68.03M | -18K | -30.13M | -138.9M | -10.98M | -3.02M | -3.73M | -1.92M |
| Dividends Paid | -76.88M | -80.79M | -67.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -470K | -25.65M | -873K | -18K | -1K | -2.48M | -1.01M | -2.92M | -3.73M | -1.92M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | -95K | 0 | 0 |
| Other Financing | 1.79M | 146.02M | 31K | 0 | -30.13M | -136.42M | -9.97M | 0 | 0 | -2.59M |
| Net Change in Cash | 59.89M▲ 0% | -160K▼ 100.3% | 181.61M▲ 113608.8% | -223.71M▼ 223.2% | 28.55M▲ 112.8% | -69.74M▼ 344.3% | -19.46M▲ 72.1% | -3.95M▲ 79.7% | 5.41M▲ 237.0% | 7.41M▲ 0% |
| Exchange Rate Effect | 1000K | 1000K | -1000K | -382K | 1000K | -470K | -1000K | 335K | -1000K | 168K |
| Cash at Beginning | 89.64M | 149.53M | 149.38M | 330.99M | 107.28M | 135.83M | 66.09M | 46.62M | 42.68M | 34.73M |
| Cash at End | 149.53M | 149.38M | 330.99M | 107.28M | 135.83M | 66.09M | 46.62M | 42.68M | 48.08M | 43.9M |
| Free Cash Flow | 470.13M▲ 0% | 458.57M▼ 2.5% | 182.29M▼ 60.2% | -1.14B▼ 726.8% | -541.77M▲ 52.6% | -394.85M▲ 27.1% | -195.93M▲ 50.4% | -59.78M▲ 69.5% | -67.45M▼ 12.8% | -96.62M▲ 0% |
| FCF Growth % | -25.88% | -2.46% | -60.25% | -726.81% | 52.58% | 27.12% | 50.38% | 69.49% | -12.83% | -207.9% |
| FCF Margin % | 22.91% | 21.44% | 8.42% | -198.32% | -294.25% | -399.97% | -337.04% | -66.99% | -119.51% | -232.38% |
| FCF per Share | 5.97 | 5.35 | 2.19 | -13.76 | -6.42 | -4.59 | -2.25 | -0.59 | -0.68 | -0.68 |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 94.64% | 106% | 119.89% | 115.79% | 21.25% | 36.49% | 53.24% | 34.51% | 62.63% | 56.52% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Return on Equity (ROE) | 3.4% | -13.65% | -53.28% | -20.58% | 8.07% | 5.84% | -17.95% | -14.45% | -136.55% | -561.72% |
| Return on Assets (ROA) | 0.78% | -2.74% | -7.98% | -2.47% | 1.28% | 1.01% | -2.88% | -2.29% | -14.18% | -17.1% |
| Equity / Assets | 21.77% | 18.55% | 10.49% | 14.23% | 17.9% | 16.54% | 15.41% | 16.4% | 3.43% | 3.04% |
| Book Value / Share | 17.3 | 14.39 | 6.68 | 6.11 | 6.26 | 4.46 | 3.27 | 2.46 | 0.45 | 0.38 |
| Debt / Equity | 0.26x | 0.21x | 0.46x | 0.50x | 0.48x | 0.66x | 0.90x | 1.02x | 5.64x | 5.64x |
| Revenue Growth | -20.26% | 4.24% | 1.22% | -73.39% | -68.04% | -46.38% | -41.11% | 53.5% | -36.75% | -57.85% |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 27, 2025·SEC
May 12, 2025·SEC
May 1, 2025·SEC
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) stock FAQ — growth, dividends, profitability & financials explained
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) saw revenue decline by 36.8% over the past year.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) reported a net loss of $211.1M for fiscal year 2024.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) has a return on equity (ROE) of -136.5%. Negative ROE indicates the company is unprofitable.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates